Key facts
- Canary Speech’s last known valuation is $22.8M (May 2022).
- It has raised $23.9M across 5 recorded rounds; the latest was Seed Round ($4.1M) in Dec 2024.
- Notable investors include Plug and Play Tech Center, Dasein Capital, Cortes Capital (Oklahoma), Hackensack Meridian Health, LG Nova — 8 tracked in total.
- Canary Speech has filed 7 Form Ds with the SEC since 2017, most recently Jan 2025 ($4.1M sold to 9 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Canary Speech
Funding rounds
5 roundsAbout Canary Speech
Developer of a speech recognition technology designed to detect neurological and cognitive diseases. The company's technology helps to monitor speech for early signs of various neurological conditions such as Parkinson's, dementia and Alzheimer's and analyzes the neurological conditions of the patients, enabling patients to identify early warning and early diagnosis of diseases that affect their cognitive functions.
- Sector
- Healthcare
- HQ
- Provo, UT, United States
- Founded
- 2016
- Employees
- 27
- Website
- canaryspeech.com/
- Ownership
- Privately Held (backing)
Canary Speech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Canary Speech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Canary Speech in its N-PORT filings yet. We sweep new filings monthly.